Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria and chloroquine for Plasmodium vivax malaria in Myanmar
ACTRN12625000119493Phase 4Completed
- Sponsor
- Mekong Malaria Elimination Program
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of artemether + lumefantrine, sponsored by Mekong Malaria Elimination Program. Started May 2025; status: completed.
02
Drugs
artemether + lumefantrine
Beyond the preview
Go deeper on ACTRN12625000119493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000119493.